Early research (Phase 1)Study completedNCT04350736
What this trial is testing
First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19
Who this might be right for
Acute Lung Injury (ALI) Associated With COVID-19Inflammatory Lung Conditions Associated With COVID-19
Theravance Biopharma 54